# Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet

> **NCT02115529** · PHASE2 · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 331 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Nabilone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02115529
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-01
- **Final completion:** 2015-11
- **Target enrollment:** 331 (ACTUAL)
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02115529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02115529, "Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02115529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*